The Factors Associated with Hepatitis C Recurrence and Sustained Virological Response in Living Donor Liver Transplant Recipients

被引:0
|
作者
Li, Wei-Feng [1 ]
Chen, Chao-Long [1 ]
Lin, Chih-Che [1 ]
Wang, Chih-Chi [1 ]
Wang, Shih-Ho [1 ]
Liu, Yueh-Wei [1 ]
Yong, Chee-Chien [1 ]
Lin, Ting-Lung [1 ]
Lin, Yu-Hung [1 ]
机构
[1] Kaohsiung Chang Gung Mem Hosp, Liver Transplantat Program, Kaohsiung, Taiwan
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S151 / S151
页数:1
相关论文
共 50 条
  • [41] Recurrence of hepatitis C in liver transplant recipients treated with mycophenolate mofetil
    Fasola, CG
    Netto, GJ
    Jennings, LW
    Christensen, LL
    Molmenti, EP
    Sanchez, EQ
    Levy, MF
    Goldstein, RM
    Klintmalm, GB
    TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1563 - 1564
  • [42] Living donor and split-liver transplants in hepatitis C recipients: Does liver regeneration increase the risk for recurrence?
    Humar, A
    Horn, K
    Kalis, A
    Glessing, B
    Payne, WD
    Lake, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (02) : 399 - 405
  • [43] PERSISTENT HISTOPATHOLOGICAL FINDINGS AFTER SUSTAINED VIROLOGICAL RESPONSE WITH DIRECT-ACTING ANTIVIRAL AGENTS FOR RECURRENT HEPATITIS C INFECTION IN LIVER TRANSPLANT RECIPIENTS
    Sanghi, Vedha
    Romero-Marrero, Carlos
    Flocco, Gianina
    Rondell, Graham
    Lopez, Rocio
    Niyazi, Fadi
    Abduljawad, Baraa
    Asfari, M.
    Eghtesad, Bijan
    Hashimoto, Koji
    Menon, Kv Narayanan
    Aucejo, Federico N.
    Yerian, Lisa M.
    Allende, Daniela
    HEPATOLOGY, 2019, 70 : 29A - 29A
  • [44] Viral genotype, immunosuppression with cyclosporine and donor age predict sustained virological response after antiviriral treatment for hepatitis C recurrence following liver transplantation
    Cescon, Matteo
    Grazi, Gian Luca
    Cucchetti, Alessandro
    Ravaioli, Mattec
    Ercolani, Giorgio
    Vivarelli, Marco
    Morelli, Maria Cristina
    Andreone, Piero
    Tame, Maria Rosa
    Sama, Claudia
    Piscaglia, Fabio
    Bolondi, Luigi
    Pinna, Antonio Daniele
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 608 - 609
  • [45] Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients
    Jain, Ashok
    Venkataramanan, Raman
    Sharma, Rajeev
    Kwong, Tai
    Orloff, Mark
    Abt, Peter
    Kashyap, Randeep
    Tsoulfas, Georgious
    Batzold, Pam
    Williamson, Mary
    Bozorgzadeh, Adel
    TRANSPLANTATION, 2008, 85 (04) : 554 - 560
  • [46] Clinical, virological, and histologic evolution of hepatitis C virus infection in liver transplant recipients
    Lumbreras, C
    Colina, F
    Loinaz, C
    Domingo, MJ
    Fuertes, A
    Dominguez, P
    Gómez, R
    Aguado, JM
    Lizasoain, M
    González-Pinto, I
    Garcia, I
    Moreno, E
    Noriega, AR
    CLINICAL INFECTIOUS DISEASES, 1998, 26 (01) : 48 - 55
  • [47] Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
    Welsch, Christoph
    Efinger, Mira
    von Wagner, Michael
    Herrmann, Eva
    Zeuzem, Stefan
    Welzel, Tania M.
    Lange, Christian M.
    PLOS ONE, 2017, 12 (02):
  • [48] Flexible and individualized treatment to achieve sustained viral response for recurrent hepatitis C in liver transplant recipients
    Lee, W. -C.
    Wu, T. -J.
    Chou, H. -S.
    Lee, C. -F.
    Chan, K. -M.
    Cheng, S. -S.
    JOURNAL OF VIRAL HEPATITIS, 2010, 17 (11) : 770 - 777
  • [49] Predictive factors for sustained virological response in the treatment of patients with chronic hepatitis C
    Svirtlih, N.
    Delic, D.
    Somonovic, J.
    Radovanovic, A.
    Mitrovic, N.
    Nikitovic, L.
    Gvozdenovic, E.
    Zerjav, S.
    Boricic, I.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E232 - E232
  • [50] Is recurrence of hepatitis C worse after living donor or deceased donor liver transplantation?
    Brown, RS
    LIVER TRANSPLANTATION, 2004, 10 (10) : 1256 - 1257